Omeros (OMER) Other Non Operating Income (2010 - 2026)
Omeros (OMER) posted Other Non Operating Income of $73.1 million for Q1 2026, down 45.49% sequentially from $134.2 million in Q4 2025, and up 112632.31% YoY from N/an in Q1 2025.
Powered by 
Analysis
Omeros (OMER) Other Non Operating Income (2010 - 2026) Analysis & Trends
Omeros has reported Other Non Operating Income for 17 years, with the latest figure at $73.1 million in Q1 2026.
- Quarterly Other Non Operating Income rose 112632.31% year-over-year to $73.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $208.1 million (up 452591.3% YoY) and the FY2025 annual result came in at -$136.7 million, down 719663.16% from the prior year.
- Other Non Operating Income fell to $73.1 million in Q1 2026 per OMER's latest filing, from $134.2 million in the prior quarter.
- Over five years, Other Non Operating Income peaked at $134.2 million in Q4 2025 and troughed at -$65000.0 in Q1 2025.
- A 5-year average of $26.7 million and a median of $735000.0 in 2022 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2024 and 2025: Other Non Operating Income sank 99.54% in 2024, then jumped 706215.79% in 2025.
- Over 5 years, Other Non Operating Income stood at $670000.0 in 2022, then jumped by 511.94% to $4.1 million in 2023, then tumbled by 99.54% to $19000.0 in 2024, then surged by 706215.79% to $134.2 million in 2025, then sank by 45.49% to $73.1 million in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $73.1 million, $134.2 million, and $800000.0 for Q1 2026, Q4 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 10 | Omeros | 1.37 Bn | 1.37 Bn | 27.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.45 Mn |
| Mar 31, 2026 | 73.15 Mn |
| Dec 31, 2025 | 134.20 Mn |
| Sep 30, 2025 | -8.82 Mn |
| Jun 30, 2025 | 8.21 Mn |
| Mar 31, 2025 | -65,000.00 |
| Dec 31, 2024 | 19,000.00 |
| Dec 31, 2023 | 4.10 Mn |
| Jun 30, 2022 | 670,000.00 |
| Mar 31, 2022 | 493,000.00 |
| Dec 31, 2021 | 526,000.00 |
| Sep 30, 2021 | 461,000.00 |
| Jun 30, 2021 | 333,000.00 |
| Mar 31, 2021 | 418,000.00 |
| Sep 30, 2020 | -13.37 Mn |
| Jun 30, 2020 | 364,000.00 |
| Mar 31, 2020 | 549,000.00 |
| Dec 31, 2019 | 292,000.00 |
| Sep 30, 2019 | 353,000.00 |
| Jun 30, 2019 | 415,000.00 |